Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06375876 · ClinicalTrials.gov registry record · NA
Single Session Intervention to Promote Hope
A NA study of Domestic Violence, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT06375876: Recruiting NA study of Domestic Violence, sponsored by Yale University.
NCT06375876 is a NA study of Domestic Violence that is actively recruiting participants, run by Yale University. The registered enrollment target is 65 participants, below the 463-participant average among 12 other Domestic Violence trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06375876, a NA study of Domestic Violence, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a brief, self-guided single-session intervention (SSI) that targets the development of, or increase in, hope, and pilot test it for the primary outcomes of feasibility, acceptability/likeability, safety, and changes in hope, and the secondary outcomes of self-worth, empowerment, and emotional wellbeing among women experiencing intimate partner violence (IPV). The study will be conducted in 2 stages: intervention development (Intervention Development Stage), and pilot testing the intervention (Pilot Stage). The focus of this registration is the Pilot Stage.
Primary Outcome
The percent of women enrolled in the study who complete the SSI and individual SSI components.
Conditions Studied
Interventions
- BEHAVIORAL Single-session intervention (SSI)
Study Locations (1)
Connecticut
- The Consultation Center at Yale - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06375876 shows while recruiting
NCT06375876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 463-participant average among 12 other Domestic Violence trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Domestic Violence appearing as the primary indexed condition, and to 1 intervention - of which Single-session intervention (SSI) is the first listed.
NCT06375876 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06375876 about?
NCT06375876 is a clinical study titled "Single Session Intervention to Promote Hope". The purpose of this study is to develop a brief, self-guided single-session intervention (SSI) that targets the development of, or increase in, hope, and pilot test it for the primary outcomes of feasibility, acceptability/likeability, safety, and changes in hope, and the secondary outcomes of self-...
What is the current status of trial NCT06375876?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-05-07. Estimated completion is 2026-01.
What conditions does trial NCT06375876 study?
This clinical trial studies the following conditions: Domestic Violence.
What interventions are being tested in trial NCT06375876?
The interventions under investigation include: Single-session intervention (SSI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06375876?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06375876 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Domestic Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06375876's enrollment target sits among peer trials
65 8th of 12 higher than 5 of 12 other Domestic Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Domestic Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Trial to Reduce Perinatal Intimate Partner Violence
RECRUITING · NA
-
Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)
RECRUITING · NA
-
Safety and Effectiveness of Computer Screening for Intimate Partner Violence
COMPLETED · NA
-
Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
-
An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI